Late effects in long-term survivors of high-grade non-Hodgkin's lymphomas

Journal of Clinical Oncology

Volumn 16, Issue 6, 1998, Pages 2070-2079

  Haddy, Theresa B ^a   Adde, Melissa A ^a   McCalla, June ^a   Domanski, Michael J ^a   Datiles III, Manuel ^a   Meehan, Sean C ^a   Pikus, Anita ^a   Shad, Aziza T ^a   Valdez, Ingrid ^a   Vivino Lopez L , Louella ^a   Magrath, Ian T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; BRAIN TOXICITY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHILD; CYANOCOBALAMIN DEFICIENCY; DOSE RESPONSE; ENDOCRINE DISEASE; ESOPHAGUS STRICTURE; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEPATITIS C; HUMAN; LARGE CELL LYMPHOMA; LYMPHOBLASTOMA; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; MUSCULOSKELETAL DISEASE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SECOND CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

EID: 0031801499     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.6.2070     Document Type: Article

References (54)

1. Ziegler JL, De Vita VT, Graw RG, et al: Combined modality treatment of American Burkitt's lymphoma. Cancer 38:2225-2231, 1976
2. Ziegler JL, Magrath IT, Deisseroth AB, et al: Combined modality treatment of Burkitt's lymphoma. Cancer Treat Rep 62:2031-2034. 1978
3. Magrath IT, Janus C, Edwards BK, et al: An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 63:1102-1111, 1984
4. Haddy TB, Adde MA, Magrath IT: CNS involvement in small noncleaved-cell lymphoma: Is CNS disease per se a poor prognostic sign? J Clin Oncol 9:1973-1982, 1991
5. Magrath I, Adde M, Shad A, et al: Adults and children with small noncleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen. J Clin Oncol 14:925-934, 1996
6. Ries LAG, Miller BA, Hankey BF, et al (eds): SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. National Cancer Institute. Bethesda, MD, NIH Pub No 94-2789, 1994
7. Carter MC, Thompson EI, Simone JV: The survivors of childhood solid tumors. Pediatr Clin North Am 38:505-526, 1991
8. Travis LB, Curtis RE, Glimelius B, et al: Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932-1937, 1993
9. Steinherz LJ, Steinherz PG, Tan CTC, et al: Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J Am Med Assoc 266:1672-1677, 1991
10. Bokemeyer C, Schmoll H-J, van Rhee J, et al: Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 68:105-110, 1994
11. Alter MJ, Mast EE: The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 23:437-455, 1994
12. Magrath IT, Haddy TB, Adde MA: Treatment of patients with high-grade non-Hodgkin's lymphomas and central nervous system involvement: Is radiation an essential component of therapy? Leuk Lymph 21:99-105, 1996
13. Shalet SM: Endocrine consequences of treatment of malignant disease. Arch Dis Child 64:1635-1641, 1989
14. The Non-Hodgkin's Lymphoma Pathologic Classification Project: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. Cancer 49:2112-2135, 1982
15. Haddy TB, Sandlund JT, Magrath IT: Testicular involvement in young patients with non-Hodgkin's lymphoma. Am J Pediatr Hematol Oncol 10:224-229, 1988
16. Haddy TB, Keenan AM, Jaffe ES, et al: Bone involvement in young patients with non-Hodgkin's lymphoma: Efficacy of chemotherapy without local radiotherapy. Blood 72:1141-1147, 1988
17. Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin's lymphomas of childhood and adolescence: Results of a treatment stratified for biologic subtypes and stage - A report of the Berlin-Frankfurt-Munster group. J Clin Oncol 13:359-372, 1995
18. Reiter A, Schrappe M, Ludwig W-D, et al: Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group. Blood 80:2471-2478, 1992
19. Schwenn MR, Blattner SR, Lynch E, et al: HiC-COM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 9:133-138, 1991
20. Patte C, Philip T, Rodary C, et al: High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: Results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 9:123-132, 1991
21. Bernstein JI, Coleman CN, Strickler JG, et al: Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types). J Clin Oncol 4:847-858, 1986
22. 2 therapy for childhood non-Hodgkin's lymphoma: A report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 11:1024-1032, 1993
23. Hoppe RT: Hodgkin's disease: Complications of therapy and excess mortality. Ann Oncol 8:115-118, 1997 (suppl 1)
24. Meadows AT, Obringer AC, Marrero O, et al: Second malignant neoplasms following childhood Hodgkin's disease: Treatment and splenectomy as risk factors. Med Pediatr Oncol 17:477-484, 1989
25. Sankila R, Garwicz S, Olsen JH, et al: Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: A population-based cohort study in the five Nordic countries. J Clin Oncol 14:1442-1446, 1996
26. Bhatia S, Robison LL, Oberlin O, et al: Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751, 1996
27. Neglia JP, Meadows AT, Robison LL, et al: Second neoplasms after acute lymphoblastic leukemia in childhood. N Engl J Med 325:1330-1336, 1991
28. Heyn R, Haeberlen V, Newton WA, et al: Second malignant neoplasms in children treated for rhabdomyosarcoma. J Clin Oncol 11:262-270, 1993
29. Mauch PM, Kalish LA, Marcus KC, et al: Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: Long-term analysis of risk factors and outcome. Blood 87:3625-3632, 1996
30. Breslow NE, Takashima JR, Whitton JA, et al: Second malignant neoplasms following treatment for Wilms' tumor: A report from the National Wilms' Tumor Study Group. J Clin Oncol 13:1851-1859, 1995
31. Doria R, Holford T, Farber LR, et al: Second solid malignancies after combined modality therapy for Hodgkin's disease. J Clin Oncol 13:2016-2022, 1995
32. Kakadekar AP, Sandor GGS, Fryer C, et al: Differences in dose scheduling as a factor in the etiology of anthracycline-induced cardiotoxicity in Ewing sarcoma patients. Med Pediatr Oncol 28:22-26, 1997
33. Lipshultz SE, Colan SD, Gelber RD, et al: Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 324:808-815, 1991
34. Lipshultz SE, Lipsitz SR, Mone SM, et al: Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. N Engl J Med 332:1738-1743, 1995
35. Nysom K, Holm K, Lipsitz SR, et al: Relationship between cumulative anthracycline dose and late cardiotoxicity in childhood acute lymphoblastic leukemia. J Clin Oncol 16:545-550, 1998
36. Dumontet C, Bastion Y, Felman P, et al: Long-term outcome and sequelae in aggressive lymphoma patients treated with the LNH-80 regimen. Ann Oncol 3:639-644, 1992
37. Muller U, Stahel RA: Gonadal function after MACOP-B or VACOP-B with or without dose intensification and ABMT in young patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 4:399-402, 1993
38. Kreuser ED, Xiros N, Hetzel WD, et al: Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 113:260-266, 1987
39. Whitehead E, Shalet SM, Blackledge G, et al: The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 49:418-422, 1982
40. Whitehead E, Shalet SM, Blackledge G, et al: The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 52:988-993, 1983
41. Green DM, Gingell RL, Pearce J, et al: The effect of mediastinal irradiation on cardiac function of patients treated during childhood and adolescence for Hodgkin's disease. J Clin Oncol 5:239-245, 1987
42. Jakacki RI, Goldwein JW, Larsen RL, et al: Cardiac dysfunction following spinal irradiation during childhood. J Clin Oncol 11:1033-1038, 1993
43. Schreiber GB, Busch MP, Kleinman SH, et al: The risk of transfusion-transmitted viral infections. N Engl J Med 334:1685-1690, 1996
44. Holland PV: Viral infections and the blood supply. N Engl J Med 334:1734-1735, 1996
45. Seeff LB: Natural history of viral hepatitis, type C. Semin Gastrointest Dis 6:20-27, 1995
46. Tong MJ, El-Farra NS, Reikes AR, et al: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463-1466, 1995
47. Hoofnagle JH, Di Bisceglie AM: The treatment of chronic viral hepatitis. N Engl J Med 336:347-356, 1997
48. Poynard T, Bedossa P, Chevallier M, et al: A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. N Engl J Med 332:1457-1462, 1995
49. Mulhern RK, Kovnar E, Langston J, et al: Long-term survivors of leukemia treated in infancy: Factors associated with neuropsychologic status. J Clin Oncol 10:1095-1102, 1992
50. Sawyer MG, Toogood I, Rice M, et al: School performance and psychological adjustment of children treated for leukemia: A long-term follow-up. Am J Pediatr Hematol Oncol 11:146-152, 1989
51. Samuelsson BO, Marky I, Rosberg S, et al: Growth and growth hormone secretion after treatment for childhood non-Hodgkin's lymphoma, Med Pediatr Oncol 28:27-34, 1997
52. Sklar C, Mertens A, Walter A, et al: Final height after treatment for childhood acute lymphoblastic leukemia: Comparison of no cranial irradiation with 1,800 and 2,400 centigrays of cranial irradiation. J Pediatr 123:59-64, 1993
53. Heyn R, Khan F, Ensign LG, et al: Acute myeloid leukemia in patients treated for rhabdomyosarcoma with cyclophosphamide and low-dose etoposide on intergroup rhabdomyosarcoma study III: An interim report. Med Pediatr Oncol 23:99-106, 1994
54. Smith MA, Rubinstein L, Ungerleider RS: Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risks. Med Pediatr Oncol 23:86-98, 1994